$country= Comparative statistics by cancer registry - SurvCan

Comparative statistics by cancer registry

Registry: Comparative statistics by cancer site

Table4: Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group

(Singapore, 1993-1997 cases followed-up until 2001)

Click on cancer site (ICD-10 code) for comparison
SiteICD-10No. of casesMaleFemaleNumber of cases by age groupRelative survival by age group
5-year survival5-year survival
No.AbsRelNo.AbsRel<4545-5455-6465-7475+<4545-5455-6465-7475+
C01-02Tongue1207324.428.24748.955.8231734202630.654.334.856.728.2
C03-06Oral cavity1359131.337.74440.946.3121639363292.344.730.147.321.0
C07-08Salivary gland875061.466.73769.972.533171414984.777.967.751.720.7
C09Tonsil382732.635.41145.549.458139380.638.748.113.00.0
C11Nasopharynx1404104654.156.935864.667.15474072811105967.160.750.651.232.7
C12-13Hypopharynx90849.411.463162028230.012.921.54.56.9
C15Oesophagus4463424.95.81046.57.78459714814838.09.14.59.80.7
C16Stomach2100128919.023.381120.023.214521145062367128.929.031.621.515.3
C17Small intestine804325.430.13718.921.3151215241426.942.728.519.313.8
C18Colon2501127041.951.3123141.649.219630355174770455.456.054.647.845.6
C19-20Rectum1753100640.348.274746.053.416224543349941454.052.457.047.344.5
C21Anus532222.731.33138.649.9141111260.076.348.232.638.8
C22Liver155012044.65.43463.64.215719136346937010.96.94.33.74.1
C23-24Gall bladder28913212.815.315711.213.0204258917825.218.816.614.34.3
C25Pancreas5122903.23.82223.64.125641151641448.13.26.42.93.0
C30-31Nose/Sinuses714930.534.92263.669.6111022171145.871.539.650.327.3
C32Larynx31128445.555.22766.776.9103788997780.978.257.056.942.7
C33-34Lung425329415.87.113126.37.2195374918152012469.813.610.05.93.7
C37-38Other thoracic organs634240.342.52152.453.83110164254.951.033.929.40.0
C40-41Bone613336.436.92837.639.844662340.711.335.556.550.4
C43Melanoma skin602828.634.13240.344.11966131647.648.635.645.121.2
C44Other skin103749076.598.054774.193.811311419323038796.395.392.996.497.5
C45Mesothelioma34266.97.3812.513.146119425.217.29.50.00.0
C47+C49Connective tissue1669653.157.27048.652.1742130241758.453.775.340.420.2
C48Peritoneum401216.717.62828.429.3129710233.434.130.511.20.0
C50Breast32041376.288.4319172.176.1936102564536922977.878.975.872.063.0
C51Vulva353554.362.0377612100.643.760.077.758.3
C53Cervix98498459.963.52732732141289677.661.358.759.243.0
C54Corpus uteri48348376.480.696140142753087.886.879.068.165.5
C56Ovary71871861.263.7270189116895483.660.552.045.924.8
C60Penis414155.566.22710166101.359.276.960.658.6
C61Prostate75275244.663.0479828336050.542.667.066.259.8
C62Testis757585.186.757972091.991.358.90.00.0
C64Kidney36925344.150.211648.051.5587687925660.864.553.445.122.3
C65Renal pelvis443125.629.71346.251.8261514750.534.621.968.80.0
C67Urinary bladder49639053.165.610647.058.2345210014716377.281.182.857.347.9
C70-72Brain & nervous system29016331.732.612728.328.81713236341743.828.89.03.70.0
C73Thyroid55412379.685.743188.291.62879374564499.895.490.166.241.5
C74Adrenal gland281435.736.31442.943.420131350.1101.90.00.00.0
C81Hodgkin lymphoma734465.768.72975.977.1421568286.154.251.460.90.0
C82-85+C96Non-Hodgkin lymphoma79047637.942.431449.554.023112215914413454.064.046.539.425.5
C90Multiple myeloma1598220.222.97714.115.7112937424045.949.620.31.73.9
C91Lymphoid leukaemia20512741.642.87850.051.0155111418751.637.123.533.50.0
C92-94Myeloid leukaemia39022416.217.316617.318.21524257756432.214.410.84.44.5
C95Leukaemia unspecified72378.18.9358.69.02748161722.30.00.00.00.0


Graphs:


Other tables available for this registry:
- Table1: Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site (Singapore, 1993-1997 cases followed-up until 2001)
- Table2b: Number and proportion of cases by vital status and median follow-up (in months) by site (Singapore, 1993-1997 cases followed-up until 2001)
- Table3: Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site (Singapore, 1993-1997 cases followed-up until 2001)
- Table4: Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group (Singapore, 1993-1997 cases followed-up until 2001)
- Table5b: Proportion (%) of cases and 5-year absolute survival by extent of disease and site (Singapore, 1993-1997)
- Table6: Comparison of 5-year absolute and relative survival of cases diagnosed between 1988-1992 and 1993-1997 (Singapore)
- Table7b: Number of cases by cancer site and calendar period (Singapore Cancer Registry, 1968-1997)
- Table8: Up-to-date 5-year relative survival estimates using cohort and period approaches by site and calendar period (Singapore, 1968-1997 cases followed-up until 1997)
- Table9: Up-to-date 10- and 15-year relative survival estimates using cohort and period approaches by site and calendar period (Singapore, 1968-1997 cases followed-up until 1997)




Registry chapter:


Consult the chapter in Cancer survival in developping countries (Volume II)